1. Search Result

Search Result

Results for "2254693-15-5" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-136198

    Syk PI3K Cancer
    SRX3207 is an orally active and first-in-class dual Syk/PI3K inhibitor, with IC50 values of 10.7 nM and 861 nM for Syk and PI3Kα, respectively. SRX3207 relieves tumor immunosuppression.